How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Teleradiology PACS Market
- By Component: Software, Hardware, Services
- By Deployment Mode: On-Premise, Cloud-Based
- By End User: Hospitals, Diagnostic Imaging Centers, Ambulatory Care Centers, Teleradiology Service Providers
- By Modality: X-ray, CT Scan, MRI, Ultrasound, Mammography
- By Application: Remote Image Interpretation, Second Opinion Services, Emergency Radiology, Routine Radiology Reporting
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Software leads By Component at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 289 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.174 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.182 →
Full report · locked preview
Everything inside the Teleradiology PACS Market report
A complete, evidence-based study - 12 chapters and 121 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Component 3
Deployment Mode 2
End User 4
Modality 5
Application 4
Companies profiled
Philips Healthcare
GE Healthcare
Siemens Healthineers
Carestream Health
Agfa HealthCare
Fujifilm Medical Systems
Merge Healthcare (IBM Watson Health)
Sectra
Infinitt Healthcare
RamSoft Inc.
TeraRecon
Visage Imaging
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Philips Healthcare
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →GE Healthcare
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Siemens Healthineers
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Carestream Health
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Agfa HealthCare
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Fujifilm Medical Systems
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Merge Healthcare (IBM Watson Health)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Sectra
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Infinitt Healthcare
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →RamSoft Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →TeraRecon
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Visage Imaging
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Intelerad Medical Systems
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →eRAD (a division of Konica Minolta)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Medicalis Corporation
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$3,330M by 2033 · 7.2% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Software77.9
- Hardware9.6
- Services12.4
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$629.3M → $1,061M · 6.7%
Europe$438.6M → $744.7M · 6.8%
Asia Pacific$400.5M → $705.3M · 7.3%
Latin America$247.9M → $468.6M · 8.3%
Middle East and Africa$190.7M → $348.7M · 7.8%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →7.162026
7.182027
7.202028
7.202029
7.212030
7.232031
7.252032
7.252033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Philips Healthcare24.0
- GE Healthcare10.3
- Siemens Healthineers13.1
- Carestream Health4.9
- Agfa HealthCare8.4
- Fujifilm Medical Systems11.4
- Others27.9
Segment contribution to growth (%)
Fig. 18 · p.39 →Component20.7%
Deployment Mode30.2%
End User11.5%
Modality24.4%
Application13.3%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America31.9
- Europe22.4
- Asia Pacific21.2
- Latin America14.1
- Middle East and Africa10.5
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Philips Healthcare | 97 | 96 | 90 | 99 | 77 | 79 | 90 |
| GE Healthcare | 83 | 79 | 83 | 82 | 82 | 93 | 84 |
| Siemens Healthineers | 65 | 70 | 69 | 69 | 65 | 77 | 69 |
| Carestream Health | 62 | 59 | 82 | 82 | 79 | 65 | 72 |
| Agfa HealthCare | 70 | 59 | 58 | 72 | 71 | 77 | 68 |
| Fujifilm Medical Systems | 61 | 61 | 51 | 64 | 47 | 47 | 55 |
| Merge Healthcare (IBM Watson Health) | 52 | 51 | 51 | 61 | 56 | 56 | 55 |
| Sectra | 50 | 36 | 59 | 50 | 54 | 44 | 49 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Philips Healthcare
- GE Healthcare
- Siemens Healthineers
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Philips Healthcare | ✓ | ✓ | ✓ | ✓ | ✓ | ◐ |
| GE Healthcare | ✓ | ✓ | ✓ | ◐ | ✓ | ✓ |
| Siemens Healthineers | ✓ | ◐ | ◐ | ◐ | ◐ | ◐ |
| Carestream Health | ◐ | ◐ | ✓ | ◐ | ◐ | ◐ |
| Agfa HealthCare | ◐ | ◐ | − | − | ✓ | ◐ |
| Fujifilm Medical Systems | ◐ | − | − | − | ◐ | ◐ |
| Merge Healthcare (IBM Watson Health) | − | − | ◐ | ◐ | ◐ | ◐ |
| Sectra | − | − | − | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Philips Healthcare90
2GE Healthcare84
3Carestream Health72
4Siemens Healthineers69
5Agfa HealthCare68
6Fujifilm Medical Systems55
7Merge Healthcare (IBM Watson Health)55
8Sectra49
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Philips HealthcareGE Healthcare
Challenger3
Strong scale, closing on the leaders.
Siemens HealthineersCarestream HealthAgfa HealthCare
Niche3
Specialists in a single segment or region.
Fujifilm Medical SystemsMerge Healthcare (IBM Watson Health)Sectra
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Component in North America, then scale across Teleradiology PACS Market — a $178M beachhead inside a $2.60B market.
Beachhead (SOM)$178Mobtainable near-term
Serviceable (SAM)$1.05Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale3 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion86 fit
Software
Best fit — highest urgency & budget in Component.
Economic buyer78 fit
Hardware
Strong fit — clear ROI and a fast path to value.
End user68 fit
Services
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Component in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Deployment Mode & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End User
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales43%
Partner / channel28%
Digital / self-serve19%
Marketplaces9%
Positioning & messaging
§GTM 2 · p.194 →For Component leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Teleradiology PACS Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified45%
Sales qualified23%
Evaluation11%
Closed-won5%
$16.7KCAC
$75KLTV
4.5:1LTV : CAC
< 3 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Teleradiology PACS Market is a durable-growth opportunity — $7.39B by 2033, compounding at 9.3%.
TAM · 2025$3.62Btoday
TAM · 2033$7.39Bforecast
CAGR9.3%2027–2033
Cumulative$47.8Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$7.39BTotal addressable market
SAM$3.07BServiceable available market
SOM$581MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →9.3% CAGR
Demand compounds through 2033, outpacing GDP across Component.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Component moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$7.39BLarge & growingTAM by 2033 at 9.3% CAGR
$3.07BServiceable nowreachable with today’s model
$581MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$5.76BBear6.1% CAGR
$7.39BBase9.3% CAGR
$9.46BBull12.3% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Deployment Mode optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Teleradiology PACS Market — a $12.5B market by 2033. Plan: grow share from 5.9% to 12.5%.
Market size · 2033$12.5Btotal addressable
Market CAGR11.2%2027–2033
Target share12.5%from 5.9% today
Revenue ambition$1.56Bby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 5.9% | 12.5% | At risk |
| Revenue | $721M | $1.56B | At risk |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | At risk |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | At risk |
| Gross margin | 34.0% | 43.6% | At risk |
| Customer retention | 89.5% | 92.2% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Component
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Deployment Mode capability
A defensible second engine — invest in Deployment Mode to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Component share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Deployment Mode
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $169M capacity & capability investment
- Greenlight bolt-on M&A in Deployment Mode
- Authorise North America expansion plan
- Fund R&D program for Component leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossOn track
- Input-cost & supply riskAhead
- Regulatory / policy changeAt risk
- Execution & talentAt risk
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Teleradiology PACS Market conversation — a $6.57B market you can size, segment and defend in minutes.
Market size · 2033$6.57Btotal opportunity
Growth7.7%CAGR to 2033
Addressable buyers1,702+accounts in scope
Typical ROI7.5×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Component
Goal Grow share in Component
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →7.5×return on cost, year one
< 3 mopayback period
$57K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
Philips HealthcareGE HealthcareSiemens HealthineersCarestream HealthAgfa HealthCareFujifilm Medical SystemsMerge Healthcare (IBM Watson Health)Sectra+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Teleradiology PACS Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Teleradiology PACS Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Telepsychiatry Software Market
Market size, share, segmentation and regional forecast.
$1.0B market · 2025 base year
View reportTelepsychiatry Service Market
Market size, share, segmentation and regional forecast.
$5.5B market · 2025 base year
View reportTelepharmacy Market
Market size, share, segmentation and regional forecast.
$3.5B market · 2025 base year
View reportTeleophthalmology Market
Market size, share, segmentation and regional forecast.
$4.4B market · 2025 base year
View reportTelemonitoring Software Market
Market size, share, segmentation and regional forecast.
$2.8B market · 2025 base year
View reportTelemetry Unit Pouch Market
Market size, share, segmentation and regional forecast.
$2.6B market · 2025 base year
View reportTelemetry Implant Market
Market size, share, segmentation and regional forecast.
$1.9B market · 2025 base year
View reportTelemedicine Workstations Market
Market size, share, segmentation and regional forecast.
$1.3B market · 2025 base year
View reportTelemedicine Virtual Healthcare Delivery Market
Market size, share, segmentation and regional forecast.
$3.8B market · 2025 base year
View reportTelemedicine Tool Market
Market size, share, segmentation and regional forecast.
$1.6B market · 2025 base year
View reportTelemedicine Technology Market
Market size, share, segmentation and regional forecast.
$6.3B market · 2025 base year
View reportTelemedicine Technologies and Services Market
Market size, share, segmentation and regional forecast.
$2.0B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.